Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms (Q34199974)

31 July 2017

Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms (English)

1 reference

31 July 2017

Patrick M Dougherty

4

0 references

Robert Dantzer

object named as

Robert Dantzer

3

0 references

Charles S Cleeland

1

object named as

Charles S Cleeland

1 reference

31 July 2017

Gary J Bennett

2

1 reference

31 July 2017

Adrian J Dunn

5

1 reference

31 July 2017

Christina A Meyers

6

1 reference

31 July 2017

Andrew H Miller

7

1 reference

31 July 2017

Richard Payne

8

1 reference

31 July 2017

James M Reuben

9

1 reference

31 July 2017

Xin Shelley Wang

10

1 reference

31 July 2017

Bang-Ning Lee

11

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

31 July 2017

1 reference

31 July 2017

97

1 reference

31 July 2017

2919-2925

1 reference

31 July 2017

11

1 reference

Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia.

31 July 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Cancer-related symptoms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

The pain of being sick: implications of immune-to-brain communication for understanding pain

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Molecular basis of sickness behavior.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Cytokine-induced sickness behavior: where do we stand?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Cytokine-induced sickness behaviour: mechanisms and implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Cognitive deficits in patients with small cell lung cancer before and after chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Endotoxin produces a depressive-like episode in rats.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Influenza virus infection of mice induces anorexia: comparison with endotoxin and interleukin-1 and the effects of indomethacin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

The roles of IL-1, IL-6, and TNFalpha in the feeding responses to endotoxin and influenza virus infection in mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Behavioral effects of cytokines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Anhedonic and anxiogenic effects of cytokine exposure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Mechanisms by which cytokines signal the brain

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

The role of the vagus nerve in cytokine-to-brain communication.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Does a neuroimmune interaction contribute to the genesis of painful peripheral neuropathies?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

A neuroimmune interaction in painful peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Neuropathic pain from an experimental neuritis of the rat sciatic nerve

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Assessment of allodynia and hyperalgesia after cisplatin administration to rats

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Opiate antinociception is altered by immunemodification: the effect of interferon, cyclosporine and radiation-induced immune suppression upon acute and long-term morphine activity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (Taxol) in murine and human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Increased release of interleukin-1 and tumour necrosis factor by interleukin-2-induced lymphokine-activated killer cells in the presence of cisplatin and FK-565

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Contribution of inflammatory cytokine release to activation of resident peritoneal macrophages after in vivo low-dose gamma-irradiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Psychiatric manifestations accompanying interferon therapy for patients with chronic hepatitis C: an overview of cases in Japan

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

A phase I trial of intermittent high-dose alpha-interferon and dexamethasone in metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

The role of cytokines in cancer-related fatigue

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Glial activation: a driving force for pathological pain

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Influence of interleukin-1beta on exploratory behaviors, plasma ACTH, corticosterone, and central biogenic amines in mice.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Sensitization to the neuroendocrine, central monoamine and behavioural effects of murine tumor necrosis factor-alpha: peripheral and central mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11382

7 January 2021

Identifiers

DOI

10.1002/CNCR.11382

1 reference

31 July 2017

1 reference